Interferon/alpha treatment decreases the number of blood eosinophils in patients with severe atopic dermatitis.
DOI:
https://doi.org/10.2340/0001555573141142Abstract
Eight patients with severe atopic dermatitis were treated with interferon/alpha (IFN/alpha 2b), given by subcutaneous injection, three times a week. The maximum doses varied from 3 to 9 x 10(6) U and the period of treatment from 6 to 14 weeks. The therapy was well tolerated. No changes were observed in eczema or IgE levels, although IFN/alpha 2b treatment significantly decreased blood eosinophils.Downloads
Download data is not yet available.
Downloads
Published
1993-04-01
How to Cite
Paukkonen, K., Fräki, J., & Horsmanheimo, M. (1993). Interferon/alpha treatment decreases the number of blood eosinophils in patients with severe atopic dermatitis. Acta Dermato-Venereologica, 73(2), 141–142. https://doi.org/10.2340/0001555573141142
Issue
Section
Articles
License
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
